Advertisement

Search Results for "Xarelto Marketing"

12:42 EDT 21st May 2013 | BioPortfolio

Original Source: Xarelto Regulatory Post-Marketing Surveillance

This study is to identify the following problems and questions with respect to the safety and effectiveness of Xarelto in comparison with other pharmacologic agents in the prophylaxis of venous thromboembolism (VTE) in a large sample of patients who undergo elective total hip replacement (THR) or total knee replacement (TKR) in the real-life conditions in its registered indication(s) as required by Korean Food and Drug Administration (KFDA). 1. Known and unknown advers...

Matching Channels

Alto Marketing - specialist healthcare and life science communications consultancy

Alto Marketing is a committed and forward-thinking specialist healthcare and life science communications consultancy.  With extensive experience of worldwide marketing in sectors including (...

Rivaroxaban

Rivaroxaban is the most broadly indicated novel oral anticoagulant and is marketed under the brand name Xarelto®. To date, Xarelto has been approved for use in the following indications across t...

Zyme Communications

Zyme Communications provides PR and marketing services for the life science sector. We support companies to raise their profile, build corporate value, and generate interest from commercial leads...

Kapler Communications - PR-led marketing communications for technology, analytical and life science companies

UK-based communications agencies with extensive experience in the life sciences - services include: Global PR services Content generation Integrated campaigns Media relations...

Antibody Drug Conjugates ADC

The humanized anti-Her2 monoclonal antibody Herceptin (trastuzumab) has become the mainstay in the treatment of Her2-positive breast cancer. Combining trastuzumab with the potent cytotoxic DM1 via a s...

Matching News

J&J Says FDA Denies New Xarelto Application

From Associated Press (March 5, 2013) NEW YORK -- Johnson & Johnson said Monday that regulators have again refused to grant a new marketing approval to its anticlotting drug Xarelto. The company h...

After latest Xarelto setback, J&J, Bayer forge ahead with 5 new trials

Johnson & Johnson and Bayer are launching five new clinical trials to test their blood thinner Xarelto in people with heart disease and other coronary conditions. The companies will test Xarelto (r...

After latest Xarelto setback, J&J, Bayer forge ahead with 5 new trials

Johnson & Johnson and Bayer are launching five new clinical trials to test their blood thinner Xarelto in people with heart disease and other coronary conditions. The companies will test Xarelto (r...

Janssen responds to FDA's Xarelto CRL; resubmits sNDA

Johnson & Johnson (NYSE: JNJ) subsidiary Janssen Research & Development, German drug major Bayer's (BAYN: DE) partner for Xarelto (rivaroxaban) in the USA, last Friday submitted the Complete Response...

F.D.A. Expedites Review of New Uses for Xarelto, an Anticlotting Drug

Companies want to expand uses of drugs like Xarelto as others lose patent protection.

FDA Again Rejects Xarelto for ACS

(MedPage Today) -- The FDA delivered a second blow to the makers of rivaroxaban (Xarelto) in their bid to treat patients with acute coronary syndromes (ACS).

Bayer’s Xarelto gets EU approval for treatment of pulmonary embolism

Regulators in Europe have given the green light to Bayer‘s anticoagulant Xarelto for the treatment of pulmonary embolism and the prevention of recurrent deep vein thrombosis. Approval by the Eur...

FDA rejects Bayer-J&J's Xarelto for acute coronary syndrome

The FDA turned down for the second time an application for the expanded use of blood thinner Xarelto, or rivaroxaban, in pati -More- 

Matching PubMed Articles

Marketing in hospitals and practices : From theory to implementation.

Although hospitals and medical practices are typical service providers from a marketing perspective, only very few engage in topics relevant to marketing. Best practice examples do, however, show how...

The Impact of Alcohol Marketing on Youth Drinking Behaviour: A Two-stage Cohort Study.

Aim: To examine whether awareness of, and involvement with alcohol marketing at age 13 is predictive of initiation of drinking, frequency of drinking and units of alcohol consumed at age 15. METHODS:...

Effectiveness of HIV Prevention Social Marketing With Injecting Drug Users.

Social marketing involves applying marketing principles to promote social goods. In the context of health behavior, it has been used successfully to reduce alcohol-related car crashes, smoking among y...

Online marketing strategies of plastic surgeons and clinics: a comparative study of the United kingdom and the United States.

The cosmetic surgery market is a rapidly growing sector of healthcare, and the use of marketing strategies is now an integral part of any cosmetic surgery practice. In this study, the authors review 5...

A Case Study of Infant Health Promotion and Corporate Marketing of Milk Substitutes.

The mismatch between the demand for, and supply of, health products has led to the increasing involvement of courts worldwide in health promotion and marketing. This study critically examines the impl...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement